M
Maurizio Rolando
Researcher at University of Genoa
Publications - 129
Citations - 8558
Maurizio Rolando is an academic researcher from University of Genoa. The author has contributed to research in topics: Medicine & Intraocular pressure. The author has an hindex of 34, co-authored 120 publications receiving 7189 citations. Previous affiliations of Maurizio Rolando include Harvard University & Vision-Sciences, Inc..
Papers
More filters
Journal ArticleDOI
The definition and classification of dry eye disease: Report of the definition and classification subcommittee of the international Dry Eye WorkShop (2007)
Michael A. Lemp,Christophe Baudouin,Jules L. Baum,Murat Dogru,Gary N. Foulks,Shigeru Kinoshita,Peter R. Laibson,James P. McCulley,Juan Murube,Stephen C. Pflugfelder,Maurizio Rolando,Ikuko Toda +11 more
TL;DR: A new definition of dry eye was developed to reflect current understanding of the disease, and a three-part classification system was recommended, based on the severity of the dry eye disease, which is expected to provide a rational basis for therapy.
Journal ArticleDOI
Dysfunctional tear syndrome: a Delphi approach to treatment recommendations.
Ashley Behrens,John Doyle,Lee Stern,Roy S. Chuck,Peter J. McDonnell,Dimitri T. Azar,Harminder S Dua,Milton Hom,Paul M. Karpecki,Peter R. Laibson,Michael A. Lemp,David M. Meisler,Juan Murube Del Castillo,Terrence P. O'Brien,Stephen C. Pflugfelder,Maurizio Rolando,Oliver D. Schein,Berthold Seitz,Scheffer C.G. Tseng,Gysbert van Setten,Steven E. Wilson,Samuel C. Yiu +21 more
TL;DR: A new term for dry eye disease was proposed: dysfunctional tear syndrome (DTS), and treatment recommendations were based primarily on patient symptoms and signs, based on consensus of expert advice.
Journal ArticleDOI
The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction.
Gerd Geerling,Joseph Tauber,Christophe Baudouin,Eiki Goto,Yukihiro Matsumoto,Terrence P. O'Brien,Maurizio Rolando,Kazuo Tsubota,Kelly K. Nichols +8 more
TL;DR: The goals of the subcommittee were to review the current practice and published evidence of medical and surgical treatment options for meibomian gland dysfunction and to identify areas with conflicting, or lack of, evidence, observations, concepts, or even mechanisms where further research is required.
Journal ArticleDOI
Role of Hyperosmolarity in the Pathogenesis and Management of Dry Eye Disease: Proceedings of the OCEAN Group Meeting
Christophe Baudouin,Pasquale Aragona,Elisabeth M. Messmer,Alan Tomlinson,Margarita Calonge,Kostas G. Boboridis,Yonca A. Akova,Gerd Geerling,Marc Labetoulle,Maurizio Rolando +9 more
TL;DR: There is now an expanding pool of clinical data on the efficacy of DED therapies that include osmoprotectants such as erythritol, taurine, trehalose and L-carnitine, which may directly protect cells against hyperosmolarity and thereby promote exit from the vicious circle of D ED physiopathology.
Journal ArticleDOI
Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction
Christophe Baudouin,Elisabeth M. Messmer,Pasquale Aragona,Gerd Geerling,Yonca A. Akova,José Benítez-del-Castillo,Kostas G. Boboridis,Jesus Merayo-Lloves,Maurizio Rolando,Marc Labetoulle +9 more
TL;DR: A new pathophysiological scheme is proposed for MGD in order to better identify the pathological mechanisms involved and to allow more efficient targeting of therapeutics, and to gain true disease status rather than being viewed as a mere dysfunction.